Immune response modifiers (under construction)

Imiquimod is a Toll-like receptor 7 (TLR7) agonist which stimulates innate and acquired immune responses locally at the site of application. Drug action results in destruction of diseased cells. Imiquimod is used to treat actinic keratosis, warts (external genital and perianal) and superficial basal cell carcinoma.